These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

564 related articles for article (PubMed ID: 23381004)

  • 1. Latest research and treatment of advanced-stage epithelial ovarian cancer.
    Coleman RL; Monk BJ; Sood AK; Herzog TJ
    Nat Rev Clin Oncol; 2013 Apr; 10(4):211-24. PubMed ID: 23381004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secondary cytoreductive surgery for isolated lymph node recurrence of epithelial ovarian cancer: a multicenter study.
    Ferrero A; Ditto A; Giorda G; Gadducci A; Greggi S; Daniele A; Fuso L; Panuccio E; Scaffa C; Raspagliesi F; Sismondi P; Biglia N
    Eur J Surg Oncol; 2014 Jul; 40(7):891-8. PubMed ID: 24378007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival outcomes after extensive cytoreductive surgery and selective neoadjuvant chemotherapy according to institutional criteria in bulky stage IIIC and IV epithelial ovarian cancer.
    Lim MC; Yoo HJ; Song YJ; Seo SS; Kang S; Kim SH; Yoo CW; Park SY
    J Gynecol Oncol; 2017 Jul; 28(4):e48. PubMed ID: 28541636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the treatment of ovarian cancer relapse.
    Saladino E; Fleres F; Irato S; Famulari C; Macrì A
    Updates Surg; 2014 Jun; 66(2):109-13. PubMed ID: 23980020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frontline treatment of epithelial ovarian cancer.
    Goh J; Mohan GR; Ladwa R; Ananda S; Cohen PA; Baron-Hay S
    Asia Pac J Clin Oncol; 2015 Dec; 11 Suppl 6():1-16. PubMed ID: 26669253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in the management of epithelial ovarian cancer.
    Berkenblit A; Cannistra SA
    J Reprod Med; 2005 Jun; 50(6):426-38. PubMed ID: 16050567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in recurrent epithelial ovarian cancer with peritoneal metastases: a single centre experience.
    Königsrainer I; Horvath P; Struller F; Grischke EM; Wallwiener D; Königsrainer A; Beckert S
    Langenbecks Arch Surg; 2014 Jun; 399(5):589-94. PubMed ID: 24817542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bevacizumab and advanced-stage ovarian cancer. Yet another oncological indication, but still best to avoid using this drug.
    Prescrire Int; 2013 Mar; 22(136):64-7. PubMed ID: 23593688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bevacizumab and paclitaxel-carboplatin chemotherapy and secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer (NRG Oncology/Gynecologic Oncology Group study GOG-0213): a multicentre, open-label, randomised, phase 3 trial.
    Coleman RL; Brady MF; Herzog TJ; Sabbatini P; Armstrong DK; Walker JL; Kim BG; Fujiwara K; Tewari KS; O'Malley DM; Davidson SA; Rubin SC; DiSilvestro P; Basen-Engquist K; Huang H; Chan JK; Spirtos NM; Ashfaq R; Mannel RS
    Lancet Oncol; 2017 Jun; 18(6):779-791. PubMed ID: 28438473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Epithelial ovarian cancer - a change of paradigm].
    Heinzelmann-Schwarz V
    Ther Umsch; 2011 Oct; 68(10):565-72. PubMed ID: 21968896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review of the current role of targeted therapies as maintenance therapies in first and second line treatment of epithelial ovarian cancer; In the light of completed trials.
    Korkmaz T; Seber S; Basaran G
    Crit Rev Oncol Hematol; 2016 Feb; 98():180-8. PubMed ID: 26603345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New paradigms in the surgical and adjuvant treatment of ovarian cancer.
    Hodeib M; Eskander RN; Bristow RE
    Minerva Ginecol; 2014 Apr; 66(2):179-92. PubMed ID: 24848076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical research in epithelial ovarian cancer and patients' outcome.
    Rochon J; du Bois A
    Ann Oncol; 2011 Nov; 22 Suppl 7():vii16-vii19. PubMed ID: 22039139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A critical appraisal of hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of advanced and recurrent ovarian cancer.
    Chiva LM; Gonzalez-Martin A
    Gynecol Oncol; 2015 Jan; 136(1):130-5. PubMed ID: 25434634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of miliary versus non-miliary sub-staging in advanced ovarian cancer.
    Eng KH; Morrell K; Starbuck K; Spring-Robinson C; Khan A; Cleason D; Akman L; Zsiros E; Odunsi K; Szender JB
    Gynecol Oncol; 2017 Jul; 146(1):52-57. PubMed ID: 28495239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How I treat ovarian cancer in older women.
    Lichtman SM
    J Geriatr Oncol; 2014 Jul; 5(3):223-9. PubMed ID: 24954887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pretreatment CA 15-3 levels do not predict disease-free survival in patients with advanced epithelial ovarian cancer.
    Gemer O; Oustinov N; Gdalevich M; Dubnik S; Levy R; Yachnin A; Lavie O; Ben Baruch N; Ben Arie A
    Tumori; 2013; 99(2):257-60. PubMed ID: 23748823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy as upfront therapy for advanced epithelial ovarian cancer: multi-institutional phase-II trial.
    Deraco M; Kusamura S; Virzì S; Puccio F; Macrì A; Famulari C; Solazzo M; Bonomi S; Iusco DR; Baratti D
    Gynecol Oncol; 2011 Aug; 122(2):215-20. PubMed ID: 21665254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for persistent and recurrent advanced ovarian carcinoma: a multicenter, prospective study of 246 patients.
    Bakrin N; Cotte E; Golfier F; Gilly FN; Freyer G; Helm W; Glehen O; Bereder JM
    Ann Surg Oncol; 2012 Dec; 19(13):4052-8. PubMed ID: 22825772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic strategies in epithelial ovarian cancer.
    Kim A; Ueda Y; Naka T; Enomoto T
    J Exp Clin Cancer Res; 2012 Feb; 31(1):14. PubMed ID: 22330607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.